ARTICLE | Distillery Therapeutics
Endocrine/metabolic; hepatic
August 16, 2018 4:06 PM UTC
Mouse studies suggest inhibiting the long non-coding RNA (lncRNA) Blnc1 could help treat obesity, hepatic steatosis and NASH. In liver samples from a mouse model of obesity and hepatic steatosis and a...
BCIQ Company Profiles
BCIQ Target Profiles